NASDAQ:CYCN | Free Cash Flow | Cyclerion Therapeutics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2018-03-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.18M$66,000.00-$1.24M
2025-12-31-$1.58M
2025-03-31-$968,000.00$0.00-$968,000.00
2024-12-31$360,000.00
2024-03-31-$1.87M
2023-12-31-$1.54M
2023-03-31-$6.21M
2022-12-31-$7.04M$0.00-$7.04M
2022-03-31-$12.84M
2021-12-31-$8.63M$0.00-$8.63M
2021-03-31-$14.46M
2020-12-31-$14.04M$35,000.00-$14.08M
2020-03-31-$29.18M$1.41M-$30.59M
2019-12-31-$22.16M$174,000.00-$22.34M
2019-03-31-$34.27M$1.81M-$36.09M
2018-12-31-$23.15M$1.82M-$24.97M
2018-03-31-$26.43M$162,000.00-$26.59M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$3.31M
2024-12-31-$4.33M
2023-12-31-$21.25M
2022-12-31-$40.61M$0.00-$40.61M
2021-12-31-$36.52M$7,000.00-$36.52M
2020-12-31-$72.49M$1.52M-$74.01M
2019-12-31-$102.22M$6.89M-$109.1M
2018-12-31-$97.5M$3.44M-$100.94M